Skip to content

Does Early Weight Loss Following Laparoscopic Sleeve Gastrectomy Affect Long-term Outcomes

Predicting Weight Loss and Comorbid Improvement Early Post-operative Weight Loss Fails to Predict Outcomes 7 Years Following Laparoscopic Sleeve Gastrectomy: Does Early Weight Loss Matter

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04235829
Enrollment
156
Registered
2020-01-22
Start date
2012-04-01
Completion date
2019-01-31
Last updated
2020-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Gastrostomy, Hypertension, Morbid Obesity, Weight Loss

Keywords

sleeve gastrectomy, morbid obesity, predicting outcomes, early weight loss, hypertension, diabetes mellitus

Brief summary

A study to explore the relationship between early weight loss in the 4 weeks following laparoscopic sleeve gastrectomy and outcomes, in terms of weight loss and comorbidity improvement, 7 years following the surgery.

Detailed description

Patients who underwent laparoscopic sleeve gastrectomy in the 6 month period between 01/04/2012 and 01/10/2019 were identified. For those meeting the inclusion criteria, demographic and medical data was extracted from hospital notes. This included initial BMI and the presence of, or treatment for, diabetes or hypertension. Using the contact details available in the medical records, a scripted telephone interview was performed. The current weight of the patient as well as a current medical and drug history were elicited. This data was compared with data attained during initial patient interaction with the service. Early weight loss, defined as weight lost in the 4 weeks following surgery, was subsequently correlated with outcomes in terms of weight loss and improvement/resolution of either hypertension or diabetes at a 7 year follow up interval.

Interventions

PROCEDURELaparoscopic sleeve gastrectomy

Form of obesity surgery

Sponsors

Shaare Zedek Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* LSG performed must have been the first surgical procedure performed for that the patient had undergone to treat their obesity * Have not undergone any further bariatric surgical procedures since the index operation * Still be alive at the time of the study * Have correct be contactable with the contact details present available in the electronic database

Exclusion criteria

* Missing data * Uncontactable * Unwilling to participate

Design outcomes

Primary

MeasureTime frameDescription
Correlation between early % total weight loss and % total weight loss 7 years following surgery.A comparison made between 4 weeks and 7 years following the index surgery.A correlation between % total weight loss 4 weeks following surgery and % total weight loss at 7 years follow up based on clinic measurements.

Secondary

MeasureTime frameDescription
Reduction or cessation in the treatment for either type 2 diabetes mellitus and hypertension 7 years following surgery..A comparison was made between pre-operative medical / medication histories and equivalent data at 7 years follow up.Reduction / resolution of either hypertension or type 2 diabetes mellitus as defined by a reduction or cessation of medical treatment for the respective comorbidity. Patient diagnoses before surgery were compared with medical and medication histories taken at 7 years follow up.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026